PRIA Logo™
117-hr-5950117th Congress

Improving Patient Access to Care and Treatment Act

Sponsored By: Representative Dean, Madeleine [D-PA-4]

Unknown

Summary

Improving Patient Access to Care and Treatment Act This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Dean, Madeleine [D-PA-4]

PA • D

Cosponsors

  • Rep. Spartz, Victoria [R-IN-5]

    IN • R

    Sponsored 11/12/2021

  • Rep. Scanlon, Mary Gay [D-PA-5]

    PA • D

    Sponsored 11/12/2021

  • Rep. Fitzpatrick, Brian K. [R-PA-1]

    PA • R

    Sponsored 11/12/2021

  • Rep. Katko, John [R-NY-24]

    NY • R

    Sponsored 11/26/2021

  • Rep. Tonko, Paul [D-NY-20]

    NY • D

    Sponsored 12/2/2021

  • Rep. Bacon, Don [R-NE-2]

    NE • R

    Sponsored 12/14/2021

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation